Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: A proof of principle on type 2 diabetes

Aging

Volumn 5, Issue 5, 2013, Pages 373-385

  Garagnani, Paolo ^a,b   Giuliani, Cristina ^a   Pirazzini, Chiara ^a   Olivieri, Fabiola ^c,d   Bacalini, Maria Giulia ^a   Ostan, Rita ^a   Mari, Daniela ^e   Passarino, Giuseppe ^f   Monti, Daniela ^g   Bonfigli, Anna Rita ^d   Boemi, Massimo ^d   Ceriello, Antonio ^h,i   Genovese, Stefano ^j   Sevini, Federica ^a   Luiselli, Donata ^a   Tieri, Paolo ^k   Capri, Miriam ^a   Salvioli, Stefano ^a   Vijg, Jan ^l   Suh, Yousin ^l,m   Delledonne, Massimo ^n,o   Testa, Roberto ^d   Franceschi, Claudio ^a   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d INRCA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF CALABRIA   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

ⁱ INSTITUTO DE SALUD CARLOS III   (Spain)

^j IRCCS MULTIMEDICA   (Italy)

^k CNR   (Italy)

^l ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^m GUANGDONG MEDICAL UNIVERSITY   (China)

ⁿ Personal Genomics SRL   (Italy)

^o UNIVERSITY OF VERONA   (Italy)

more..

Author keywords

Age related diseases; Centenarians; Extreme phenotypes; TCF7L2; Type 2 diabetes

Indexed keywords

EID: 84880397970     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100562     Document Type: Article

References (89)

1. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nature Genetics. 2008; 40:695-701.
2. Tazearslan C, Cho M, Suh Y. Discovery of functional gene variants associated with human longevity: opportunities and challenges. J. Gerontol. A Biol. Sci. Med. Sci. 2012; 67:376-383.
3. Heutink P, Oostra BA. Gene finding in genetically isolated populations. Hum. Mol. Genet. 2002; 11:2507-2515.
4. Garagnani P, Laayouni H, González-Neira A, Sikora M, Luiselli D, Bertranpetit J, et al. Isolated populations as treasure troves in genetic epidemiology: the case of the Basques. Eur. J. Hum. Genet. 2009; 17:1490-1494.
5. Lowe JK, Maller JB, Pe'er I, Neale BM, Salit J, Kenny EE, et al. Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. PLoS Genet. 2009; 5:e1000365.
6. Franceschi C, Bonafé M. Centenarians as a model for healthy aging. Biochem. Soc. Trans. 2003; 31:457-461.
7. Paolisso G, Gambardella A, Ammendola S, D'amore A, Balbi V, Varricchio M, et al. Glucose tolerance and insulin action in healty centenarians. Am. J. Physiol. 1996; 270:E890-894.
8. Paolisso G, Barbieri M, Rizzo MR, Carella C, Rotondi M, Bonafé M, et al. Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. Exp. Gerontol. 2001; 37:149-156.
9. Vitale G, Brugts MP, Ogliari G, Castaldi D, Fatti LM, Varewijck AJ, et al. Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY). 2012; 4:580-589.
10. Evert J, Lawler E, Bogan H, Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J. Gerontol. A Biol. Sci. Med. Sci. 2003; 58232-52837.
11. Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, Barzilai N. Clinical phenotype of families with longevity. J Am Geriatr Soc. 2004; 52:274-277
12. Westendorp RGJ, van Heemst D, Rozing MP, Frölich M, Mooijaart SP, Blauw G-J, et al. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc. 2009; 57:1634-1637.
13. Wijsman CA, Rozing MP, Streefland TCM, le Cessie S, Mooijaart SP, Slagboom PE, et al. Familial longevity is marked by enhanced insulin sensitivity. Aging Cell. 2011; 10:114-121.
14. Kowall B, Peters A, Thorand B, Rathmann W, Meisinger C. Associations between longevity of parents and glucose regulation in their offspring: the KORA S4/F4 Study. Diabetologia. 2013; 56:268-274.
15. Testa R, Olivieri F, Bonfigli AR, Sirolla C, Boemi M, Marchegiani F, et al. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients. Diabetes Res. Clin. Pract. 2006; 71:299-305.
16. Cormio A, Milella F, Marra M, Pala M, Lezza AMS, Bonfigli AR, et al. Variations at the H-strand replication origins of mitochondrial DNA and mitochondrial DNA content in the blood of type 2 diabetes patients. Biochim. Biophys. Acta. 2009; 1787: 547-552.
17. Bonfigli AR, Sirolla C, Testa R, Cucchi M, Spazzafumo L, Salvioli S, et al. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study. Acta Diabetol. 2012; in press.
18. Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, et al. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects. Nephrol. Dial. Transplant. 2013; 28:964-971
19. Spazzafumo L, Olivieri F, Abbatecola AM, Castellani G, Monti D, Lisa R, et al. Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes. Age (Dordr). 2013; 35:419-429.
20. Forte GI, Pilato G, Vaccarino L, Sanacore M, Candore G, Romano GC, et al. Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complications. Curr. Pharm. 2010; 16:898-903.
21. Testa R, Olivieri F, Sirolla C, Spazzafumo L, Rippo MR, Marra M, et al. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabet. Med. 2011; 28:1388-1394.
22. Achilli A, Olivieri A, Pala M, Hooshiar Kashani B, Carossa V, Perego UA, et al. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS ONE. 2011; 6:e21029.
23. Grant SFA, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006; 38:320-323.
24. Zhao J, Schug J, Li M, Kaestner KH, Grant SFA. Diseaseassociated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Diabetologia. 2010; 53:2340-2346.
25. Franceschi C, Bonafé M. Centenarians as a model for healthy aging. Biochem. Soc. Trans. 2003; 31:457-461.
26. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000; 20:1595-1599.
27. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care. 2003; 26:2015- 2020.
28. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002; 360:57- 58.
29. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for earlyonset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 2000; 67:1470-1480.
30. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and metaanalysis. Diabetologia. 2011; 54:2303-2314.
31. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 2012; 44:991-1005.
32. Mohlke KL, Boehnke M, Abecasis GR. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Hum. Mol. Genet. 2008; 17:R102-108.
33. Sousa AG, Selvatici L, Krieger JE, Pereira AC. Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis. Rev Diabet Stud. 2011; 8:230-244.
34. Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D'amato C, Novelli G, et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol. 2012; in press.
35. Muendlein A, Saely CH, Geller-Rhomberg S, Sonderegger G, Rein P, Winder T, et al. Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. PLoS ONE. 2011; 6: e17978
36. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V, Einarsdottir AS, et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 2003; 73:323-335.
37. Mayans S, Lackovic K, Lindgren P, Ruikka K, Agren A, Eliasson M, et al. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur. J. Hum. Genet. 2007; 15:342- 346.
38. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445:881-885.
39. Stitzel ML, Sethupathy P, Pearson DS, Chines PS, Song L, Erdos MR, et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab. 2010; 12:443-455.
40. Van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, van Haeften TW, Hofker MH, et al. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. Diabetologia. 2007; 50:59-62.
41. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest. 2007; 117:2155-2163.
42. Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP, et al. A map of open chromatin in human pancreatic islets. Nat. Genet. 2010; 42:255-259.
43. Ip W, Chiang Y-TA, Jin T. The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective. Cell Biosci. 2012; 2:28.
44. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes. 2009; 58:2718-2725.
45. Pinney SE, Simmons RA. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol. Metab. 2010; 21:223-229.
46. Pons D, de Vries FR, van den Elsen PJ, Heijmans BT, Quax PHA, Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur. Heart J. 2009; 30:266-277.
47. Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am. J. Physiol. Renal Physiol. 2010; 299:F14-25.
48. Pimentel-Coelho PM, Rivest S. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Eur. J. Neurosci. 2012; 35:1917-1937.
49. Camici PG. Coronary microvascular dysfunction in patients with cardiomyopathies. Circ Heart Fail. settembre 2008; 1:150-152.
50. Sainz J, Rudolph A, Hoffmeister M, Frank B, Brenner H, Chang-Claude J, et al. Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk. J. Clin. Endocrinol. Metab. 2012; 97:E845-851.
51. Sun J, Wang D, Jin T. Insulin alters the expression of components of the Wnt signaling pathway including TCF-4 in the intestinal cells. Biochim. Biophys. Acta. 2010; 1800:344-351.
52. Jin T. Why diabetes patients are more prone to the development of colon cancer? Med. Hypotheses. 2008; 71:241-244.
53. Vidal M, Cusick ME, Barabási A-L. Interactome networks and human disease. Cell. 2011; 144:986-998.
54. Moonesinghe R, Khoury MJ, Liu T, Ioannidis JPA. Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc. Natl. Acad. Sci. U.S.A. 2008; 105:617-622.
55. Perry JRB, Voight BF, Yengo L, Amin N, Dupuis J, Ganser M, et al. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet. 2012; 8:e1002741.
56. Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum. Mol. Genet. 2010; 19:2706-2715.
57. Tsai F-J, Yang C-F, Chen C-C, Chuang L-M, Lu C-H, Chang C-T, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010; 6:e1000847.
58. Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi M, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat. Genet. 2010; 42:864-868.
59. Mtiraoui N, Ezzidi I, Turki A, Chaieb A, Mahjoub T, Almawi WY. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res. Clin. Pract. 2012; 97:290-297.
60. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010; 42:105-116.
61. Williams WW, Salem RM, McKnight AJ, Sandholm N, Forsblom C, Taylor A, et al. Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes. 2012; 61:2187-2194.
62. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010; 42:579-589.
63. Gu HF, Zheng X, Abu Seman N, Gu T, Botusan IR, Sunkari VG, et al. Impact of the Hypoxia-Inducible Factor-1 a (HIF-1a) Pro582Ser Polymorphism on Diabetes Nephropathy. Diabetes Care. 2013; 36:415-421.
64. Ghattas MH, Abo-Elmatty DM. Association of polymorphic markers of the catalase and superoxide dismutase genes with type 2 diabetes mellitus. DNA Cell Biol. 2012; 31:1598-1603.
65. Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, et al. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. PLoS ONE. 2010; 5:e9462.
66. Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, et al. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects. Nephrol. Dial. Transplant. 2013; 28:964-971.
67. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316:889-894.
68. Sällman Almén M, Rask-Andersen M, Jacobsson JA, Ameur A, Kalnina I, Moschonis G, et al. Determination of the obesityassociated gene variants within the entire FTO gene by ultradeep targeted sequencing in obese and lean children. Int J Obes (Lond). 2013; 37:424-314.
69. Jacobsson JA, Schiöth HB, Fredriksson R. The impact of intronic single nucleotide polymorphisms and ethnic diversity for studies on the obesity gene FTO. Obes Rev. 2012; 13:1096-1109.
70. Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 2007; 39:724-726.
71. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and metaanalysis. Diabetologia. 2011; 54:2303-2314.
72. Hivert M-F, Manning AK, McAteer JB, Florez JC, Dupuis J, Fox CS, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes. 2008; 57:3353-3359.
73. Ericson U, Rukh G, Stojkovic I, Sonestedt E, Gullberg B, Wirfält E, et al. Sex-specific interactions between the IRS1 polymorphism and intakes of carbohydrates and fat on incident type 2 diabetes. Am. J. Clin. Nutr. 2013; 97:208-216.
74. Olivieri F, Lazzarini R, Recchioni R, Marcheselli F, Rippo MR, Di Nuzzo S, et al. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr). 2012; in press .
75. Olivieri F, Lorenzi M, Antonicelli R, Testa R, Sirolla C, Cardelli M, et al. Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction. Atherosclerosis. 2009; 206:588-593
76. Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, et al Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology. 22 marzo 2011; 76:1059-1065.
77. Mantovani V, Garagnani P, Selva P, Rossi C, Ferrari S, Cenci M, et al. Simple method for haplotyping the poly(TG) repeat in individuals carrying the IVS8 5T allele in the CFTR gene. Clin. Chem. 2007;53:531-533.
78. González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007; 23:644-645.
79. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007; 81:559-575.
80. Prieto C, De Las Rivas J. APID: Agile Protein Interaction DataAnalyzer. Nucleic Acids Res. 2006; 34:W298-302.
81. Hernandez-Toro J, Prieto C, De las Rivas J. APID2NET: unified interactome graphic analyzer. Bioinformatics. 2007; 23:2495-2497.
82. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, Barsky A, et al. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 2008; 4:218.
83. Killcoyne S, Carter GW, Smith J, Boyle J. Cytoscape: a community-based framework for network modeling. Methods Mol. Biol. 2009; 563:219-239.
84. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011; 27:431-432.
85. Platzer A, Perco P, Lukas A, Mayer B. Characterization of protein-interaction networks in tumors. BMC Bioinformatics. 2007; 8:224.
86. Barabási A-L, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004; 5:101-113.
87. Yoon J, Blumer A, Lee K. An algorithm for modularity analysis of directed and weighted biological networks based on edgebetweenness centrality. Bioinformatics. 2006; 22:3106-3108.
88. Assenov Y, Ramírez F, Schelhorn S-E, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008; 24:282-284.
89. Potapov AP, Voss N, Sasse N, Wingender E. Topology of mammalian transcription networks. Genome Inform. 2005; 16:270-278.